SCHEDULE 13G 0001602744 XXXXXXXX LIVE Common Stock, par value $0.001 per share 06/30/2025 0001611115 Omada Health, Inc. 68170A108 611 Gateway Blvd, Suite 120 South San Francisco CA 94080 Rule 13d-1(d) U.S. Venture Partners X, L.P. b DE 0 4571769 0 4571769 4571769 N 7.9 PN The reported securities are owned directly by U.S. Venture Partners X, L.P. (USVP X). Presidio Management Group X, L.L.C. (PMG X) is the general partner of each of the USVP X Funds (as defined below) and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP X Funds. Dr. Jonathan Root, a member of the Issuer's board of directors, Irwin Federman, Steven Krausz and Richard Lewis are the managing members of PMG X, who may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. In addition, Casey M. Tansey is the managing partner of PMG X and may be deemed to share voting and dispositive power over the reported securities held by the USVP X Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP X Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 57,574,921 shares of Common Stock outstanding as of August 5, 2025 as reported by the Issuer in its Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission (the Commission) on August 8, 2025 (the Form 10-Q). USVP X Affiliates, L.P. b DE 0 146257 0 146257 146257 N 0.3 PN Consists of (i) 4,571,769 shares of Common Stock held directly by USVP X, and (ii) 146,257 shares of Common Stock held directly by USVP X Affiliates. PMG X is the general partner of each of the USVP X Funds and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP X Funds. Dr. Jonathan Root, a member of the Issuer's board of directors, Irwin Federman, Steven Krausz and Richard Lewis are the managing members of PMG X, who may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. In addition, Casey M. Tansey is the managing partner of PMG X and may be deemed to share voting and dispositive power over the reported securities held by the USVP X Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP X Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 57,574,921 shares of Common Stock outstanding as of August 5, 2025 as reported by the Issuer in its Form 10-Q. Presidio Management Group X, L.L.C. b DE 0 4718026 0 4718026 4718026 N 8.2 OO Consists of (i) 4,571,769 shares of Common Stock held directly by USVP X, and (ii) 146,257 shares of Common Stock held directly by USVP X Affiliates. PMG X is the general partner of each of the USVP X Funds and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP X Funds. Dr. Jonathan Root, a member of the Issuer's board of directors, Irwin Federman, Steven Krausz and Richard Lewis are the managing members of PMG X, who may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. In addition, Casey M. Tansey is the managing partner of PMG X and may be deemed to share voting and dispositive power over the reported securities held by the USVP X Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP X Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 57,574,921 shares of Common Stock outstanding as of August 5, 2025 as reported by the Issuer in its Form 10-Q. Casey M Tansey b X1 0 4718026 0 4718026 4718026 N 8.2 IN Consists of (i) 4,571,769 shares of Common Stock held directly by USVP X, and (ii) 146,257 shares of Common Stock held directly by USVP X Affiliates. PMG X is the general partner of each of the USVP X Funds and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP X Funds. Dr. Jonathan Root, a member of the Issuer's board of directors, Irwin Federman, Steven Krausz and Richard Lewis are the managing members of PMG X, who may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. In addition, Casey M. Tansey is the managing partner of PMG X and may be deemed to share voting and dispositive power over the reported securities held by the USVP X Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP X Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 57,574,921 shares of Common Stock outstanding as of August 5, 2025 as reported by the Issuer in its Form 10-Q. Omada Health, Inc. 611 Gateway Blvd, Suite 120, South San Francisco, CA 94080 This Schedule 13G is being filed on behalf of (i) U.S. Venture Partners X, L.P., a Delaware limited partnership, (ii) USVP X Affiliates, L.P., a Delaware limited partnership, (iii) Presidio Management Group X, L.L.C., a Delaware limited liability company and (iv) Casey M. Tansey, a citizen of the United States (the foregoing entities and individuals are collectively referred to as the Reporting Persons). The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G. The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached to this Statement as Exhibit 1. Other than those securities reported herein as being held directly by such Reporting Person, each Reporting Person disclaims beneficial ownership of all securities reported in this Statement except to the extent of such Reporting Person's pecuniary interest therein. The principal business office of the Reporting Persons is 1460 El Camino Real, Suite 100, Menlo Park, California 94025. See Item 2(a) Y See Row 9 of the cover page for each Reporting Person and the corresponding comments. See Row 11 of the cover page for each Reporting Person and the corresponding comments. See Row 5 of the cover page for each Reporting Person and the corresponding comments. See Row 6 of the cover page for each Reporting Person and the corresponding comments. See Row 7 of the cover page for each Reporting Person and the corresponding comments. See Row 8 of the cover page for each Reporting Person and the corresponding comments. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. U.S. Venture Partners X, L.P. /s/ Dale Holladay 08/14/2025 USVP X Affiliates, L.P. /s/ Dale Holladay 08/14/2025 Presidio Management Group X, L.L.C. /s/ Dale Holladay 08/14/2025 Casey M Tansey /s/ Dale Holladay, Attorney-in-Fact for Casey M. Tansey 08/14/2025